Allied Healthcare Products, Inc. provided earnings guidance for the quarter ended September 30, 2022. For the quarter, the company expects to report a loss of $1.6 million before taxes, compared to a loss of $1.0 million before taxes for the same period of fiscal year 2022. Net sales for the quarter of $5.2 million are expected to be $2.2 million or 29.7% lower than the comparable quarter in fiscal 2022.
Allied Healthcare Products, Inc.
Equities
AHPIQ
US0192222075
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 401 | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- AHPIQ Stock
- News Allied Healthcare Products, Inc.
- Allied Healthcare Products, Inc. Provides Earnings Guidance for the Quarter Ended September 30, 2022